Literature DB >> 35144751

Echocardiographic Deformation Imaging for Early Detection of Genetic Cardiomyopathies: JACC Review Topic of the Week.

Karim Taha1, Feddo P Kirkels2, Arco J Teske3, Folkert W Asselbergs4, J Peter van Tintelen5, Pieter A Doevendans6, Shelby Kutty7, Kristina H Haugaa8, Maarten J Cramer9.   

Abstract

Clinical screening of the relatives of patients with genetic cardiomyopathies is challenging, as they often lack detectable cardiac abnormalities at presentation. Life-threatening adverse events can already occur in these early stages of disease, so sensitive tools to reveal the earliest signs of disease are needed. The utility of echocardiographic deformation imaging for early detection has been explored for this population in multiple studies but has not been broadly implemented in clinical practice. The authors discuss contemporary evidence on the utility of deformation imaging in relatives of patients with genetic cardiomyopathies. The available body of data shows that deformation imaging reveals early disease-specific abnormalities in dilated cardiomyopathy, hypertrophic cardiomyopathy, and arrhythmogenic cardiomyopathy. Deformation imaging seems promising to enhance the screening and follow-up protocols in relatives, and the authors propose measures to accelerate its implementation in clinical care.
Copyright © 2022 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  deformation imaging; early detection; family screening; genetic cardiomyopathy; speckle tracking

Mesh:

Year:  2022        PMID: 35144751     DOI: 10.1016/j.jacc.2021.11.045

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  1 in total

Review 1.  State-of-the-Art Multimodality Imaging in Sudden Cardiac Arrest with Focus on Idiopathic Ventricular Fibrillation: A Review.

Authors:  Lisa M Verheul; Sanne A Groeneveld; Feddo P Kirkels; Paul G A Volders; Arco J Teske; Maarten J Cramer; Marco Guglielmo; Rutger J Hassink
Journal:  J Clin Med       Date:  2022-08-10       Impact factor: 4.964

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.